Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumoperitoneum and botulinum toxin for abdominal wall reconstruction
IRCT20230408057846N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of neuronox in abdominal hernia, sponsored by Mashhad University of Medical Sciences. Started Apr 2023; status: completed.
02
Drugs
neuronox
03
Conditions
abdominal hernia
Beyond the preview
Go deeper on IRCT20230408057846N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230408057846N1.